On March 31, 2026, William Blair upgraded 10x Genomics from “Market Perform” to “Outperform,” highlighting its best-in-class genomics platforms and exposure to growing demand for large-scale ...

Genomics (TXG) has drawn investor attention after recent share price gains over the past week, month, and past 3 months, prompting closer scrutiny of its current valuation and business fundamentals.

Bionano Genomics BNGO just pulled back the curtain on its fourth-quarter results, and the message is clear: the company is ...

William Blair upgraded 10x Genomics Inc. TXG stock, citing it as the best-in-class technology and is well-positioned to ...

The market misinterprets past COVID-era revenue growth for 10x Genomics and fails to integrate current sector growth. Read ...

The growing investing icon was skimpy on her purchases last week, making the names she did buy that much more interesting.

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

The widely followed investor has been buying stocks trading well below their all-time highs.

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

Cathie Wood’s ARK ETF published their daily trades for Monday, March 23rd, 2026, highlighting a continued focus on biotechnology and a reduction in fintech exposure. The most si ...